Official-source baseline for AbbVie using SEC submissions, FY2025 10-K, Q1 FY2026 10-Q, filed Q1 2026 results, FY2025 results exhibit, proxy materials, annual meeting results, debt filings, and official peer filings.
References
Sources used in this report
Annual reportAbbVie FY2025 Form 10-K2026-02-20 · Business model, products, FY2025 financials, risk factors, patent timing, customer concentration, and capital allocation.Quarterly reportAbbVie Q1 FY2026 Form 10-Q2026-05-08 · Latest financials, balance sheet, cash flow, debt issuance, product revenue, legal matters, and policy updates.Company results releaseAbbVie Q1 2026 results exhibit2026-04-29 · Q1 revenue growth, adjusted EPS, product-franchise results, guidance, and pipeline updates.Company results releaseAbbVie FY2025 results exhibit2026-02-04 · FY2025 product revenue breakdown and operating trends.Proxy statementAbbVie 2026 DEF 14A proxy statement2026-03-23 · Board, leadership, independence, compensation, and governance practices.